Anthony Udo-Inyang, MD
Obstetrics & Gynecology · Taylor, MINPI 1285609826
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $556 of the $762 with a category attached, or 72.9%. 13 manufacturers reported payments, led by Myovant Sciences Inc. at 34.9% of the total. Reporting peaked in 2021 at $309 and has fallen 72.9% since, to $84 in 2025.
Across 37 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$266
- AbbVie$105
- Sage Therapeutics, LLC$84
- Aspira Women's Health Inc$78
- Pfizer$71
- Avion Pharmaceuticals$27
- plus $131 from 7 others
What the payments were for
- Food & beverage$55673%
- Education$20727%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 14 | $266 |
| AbbVie | 6 | $105 |
| Sage Therapeutics, LLC | 3 | $84 |
| Aspira Women's Health Inc | 1 | $78 |
| Pfizer | 4 | $71 |
| Avion Pharmaceuticals | 2 | $27 |
| Shield Therapeutics Inc | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Meditrina | 1 | $21 |
| Exeltis, USA Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
How this compares
$762 in reported general payments places this provider in the 60th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 19 | $104 |
| Estradiol | 24 | $89 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Taylor
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Jay FisherWest Bloomfield$136K
- Barbara DepreeZeeland$118K
- Rabbie HannaDetroit$105K
- Gregory GresselGrand Rapids$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.